News | February 02, 2022
Panacea Biotec sells its domestic formulations business to Mankind Pharma
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
Domestic business was up 41.9% YoY and 27.7% QoQ
Biocon Pharma will be responsible for drug development and manufacturing, while Libbs will leverage its deep expertise and reach in Brazil to import, distribute and market
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
The transaction marks a clear portfolio reshuffle for Indoco
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
Subscribe To Our Newsletter & Stay Updated
